MODIFIED FLUORINATED NUCLEOSIDE ANALOGUES
6 Assignments
0 Petitions
Accused Products
Abstract
The disclosed invention provides compositions and methods of treating a Flaviviridae infection, including hepatitis C virus, West Nile Virus, yellow fever virus, and a rhinovirus infection in a host, including animals, and especially humans, using a (2′R)-2′-deoxy-2′-fluoro-2′-C-methyl nucleosides, or a pharmaceutically acceptable salt or prodrug thereof.
-
Citations
176 Claims
-
1-153. -153. (canceled)
-
154. A method of inhibiting the proliferation of a Flaviviridae virus in a host comprising penetrating a cell infected with the virus with an antivirally effective amount of a (2′
- R)-2′
-deoxy-2′
-fluoro-2′
-C-methyl nucleoside (β
-D or β
-L) or its pharmaceutically acceptable salt of the structure;
- View Dependent Claims (155, 156, 157, 158, 159, 176)
- R)-2′
-
160. A method of inhibiting the proliferation of a Flaviviridae virus in a host comprising penetrating a cell infected with the virus with an antivirally effective amount of a (2′
- R)-2′
-deoxy-2′
-fluoro-2′
-C-methyl nucleoside (β
-D) or its pharmaceutically acceptable salt of the structure;
- View Dependent Claims (161)
- R)-2′
-
162. A method of inhibiting the proliferation of a Flaviviridae virus in a host comprising penetrating a cell infected with the virus with an antivirally effective amount of a (2′
- R)-2′
-deoxy-2′
-fluoro-2′
-C-methyl nucleoside (β
-D) or its pharmaceutically acceptable salt of the structure;
- View Dependent Claims (163)
- R)-2′
-
164. A method of inhibiting the proliferation of a Flaviviridae virus in a host comprising penetrating a cell infected with the virus with an antivirally effective amount of a (2′
- R)-2′
-deoxy-2′
-fluoro-2′
-C-methyl nucleoside (β
-D or β
-L) or its pharmaceutically acceptable salt in a pharmaceutically acceptable carrier. - View Dependent Claims (165)
- R)-2′
-
166. A method of inhibiting the proliferation of a Flaviviridae virus in a host comprising penetrating a cell infected with the virus with an antivirally effective amount of a pharmaceutical composition comprising a (2′
- R)-2′
-deoxy-2′
-fluoro-2′
-C-methyl nucleoside (β
-D or β
-L) or its pharmaceutically acceptable salt of the structure;
- View Dependent Claims (167, 168, 169, 170, 171)
- R)-2′
-
172. A method of inhibiting the proliferation of a Flaviviridae virus in a host comprising penetrating a cell infected with the virus with an antivirally effective amount of a pharmaceutical composition comprising a (2′
- R)-2′
-deoxy-2′
-fluoro-2′
-C-methyl nucleoside (β
-D) or its pharmaceutically acceptable salt of the structure;
- View Dependent Claims (173)
- R)-2′
-
174. A method of inhibiting the proliferation of a Flaviviridae virus in a host comprising penetrating a cell infected with the virus with an antivirally effective amount of a pharmaceutical composition comprising a (2′
- R)-2′
-deoxy-2′
-fluoro-2′
-C-methyl nucleoside (β
-D) or its pharmaceutically acceptable salt of the structure;
- View Dependent Claims (175)
- R)-2′
Specification